Gene · 7477
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Steroid receptors and coregulators: Dissemination of sex differences and emerging technologies. | J Biol Chem | 2025 | 40023399 | PubTator, text mining | PubMed |
| Identification of lncRNA-miRNA-mRNA ceRNA axes and KEGG pathways related to uveal melanoma metastasis. | Technol Health Care | 2025 | 39973883 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study and Rare Variant Analysis for Dupuytren Disease in a North American Population. | J Hand Surg Am | 2025 | 39570219 | PubTator, text mining | PubMed |
| Activation of the WNT7B/β-Catenin Pathway Initiates GLUT1 Expression and Promotes Aerobic Glycolysis in Colorectal Cancer Cells. | Nutr Cancer | 2025 | 39434562 | PubTator, text mining | PubMed |
| RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway. | Cell Mol Gastroenterol Hepatol | 2025 | 39278404 | PubTator, text mining | PubMed |
| WNT7B promotes cancer progression via WNT/β-catenin signaling pathway and predicts a poor prognosis in oral squamous cell carcinoma. | BMC Oral Health | 2024 | 39487430 | PubTator, text mining | PubMed |
| Wnt7b overexpression in osteoblasts stimulates bone formation and reduces obesity in mice on a high-fat diet. | JBMR Plus | 2024 | 39434845 | PubTator, text mining | PubMed |
| Anti-metastatic Effects of Bee Venom and Melittin in Breast Cancer Cells by Upregulation of BRMS1 and DRG1 Genes. | Chem Biol Drug Des | 2024 | 39396919 | PubTator, text mining | PubMed |
| Acute myeloid leukemia cells adhere to bone marrow and acquire chemoresistance by downregulating UNC5B expression. | Front Oncol | 2024 | 39381040 | PubTator, text mining | PubMed |
| Wnt7B enhances the osteogenic differentiation of lipopolysaccharide-stimulated human periodontal ligament stem cells and inhibits the M1 polarization of macrophages by binding FZD4. | Mol Med Rep | 2024 | 39301638 | PubTator, text mining | PubMed |
| CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression. | Cancer Res | 2024 | 39288082 | PubTator, text mining | PubMed |
| A pan-cancer analysis of Wnt family member 7B in human cancers. | Cancer Innov | 2024 | 39257440 | PubTator, text mining | PubMed |
| Frizzled 6 endows high-grade serous ovarian cancer with stem-like properties and chemoresistance. | Mol Carcinog | 2024 | 39129468 | PubTator, text mining | PubMed |
| We need to talk-how muscle stem cells communicate. | Front Cell Dev Biol | 2024 | 39050890 | PubTator, text mining | PubMed |
| Mutational and transcriptional profile predicts the prognosis of stage IV gastric cancer - Prognostic factors for metastatic gastric cancer. | Arab J Gastroenterol | 2024 | 39043541 | PubTator, text mining | PubMed |
| LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis. | Gene | 2024 | 38734188 | PubTator, text mining | PubMed |
| miR-199a-5p modulates choroidal neovascularization by regulating Wnt7b/Wnt/β-catenin signaling pathway. | J Mol Histol | 2024 | 38662168 | PubTator, text mining | PubMed |
| A founder variant expands the phenotype of WNT7B-related PDAC syndrome. | Clin Genet | 2024 | 38417950 | PubTator, text mining | PubMed |
| The evolving roles of Wnt signaling in stem cell proliferation and differentiation, the development of human diseases, and therapeutic opportunities. | Genes Dis | 2024 | 38292186 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism: Metabolic alterations in the progression of osteosarcoma. | J Bone Oncol | 2024 | 38288377 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7477/papers?page=4